People with multiple myeloma which has come back or stopped responding to treatment may be able to join the MagnetisMM-32 trial. Together, we could make a difference.     For more details about Pfizer’s MagnetisMM-32 clinical trial, please visit: https://www.pfizerclinicaltrials.com/nct06152575-multiple-myeloma-trial?cmp=789d7f1a-53cf-4154-bafc-ad212d49eef7&ttype=FB